We've put some small files called cookies on your device to make our site work.
We would also like to use google translate cookies and analytical cookies to understand how our site is used and improve user experience. Analytical cookies send information to Google Analytics.
Let us know your preference. We will use a cookie to save your choice. Before you make your choice you can read more about our cookie policy.
You can change your cookie settings at any time using our cookie policy.
Mounjaro (tirzepatide) – Who Can Get It on the NHS?
We've had many questions about Mounjaro, the new weight loss injection. Here's what you need to know:Surgeries in Herts and West Essex are not able to supply this at present as we are awaiting further
The national data opt-out service was introduced in May 2018. It enables patients to stop their confidential, identifiable information being used for research or planning purposes. The change is a result of the recommendations set out in the Review of Data Security, Consent and Opt-Outs by the National Data Guardian.
Previous to May 2018 there were two ways in which a patient could opt out of sharing their personal information these were:
A type 1 opt out. This prevented confidential information being shared outside a GP practice for purposes other than direct care.
A type 2 opt out. This prevented confidential information being shared outside NHS Digital for purposes beyond the individual's direct care.
The national data opt-out has replaced the Type 2 opt-out. By 31st March 2022 all health and care organisations are required to be compliant with the national data opt-out policy.